Kisker lab: 5B5Q: Difference between revisions
Line 14: | Line 14: | ||
<StructureSection load='' size='540' side='right' caption='Caption for this structure' scene='78/781027/Panela/3'> | <StructureSection load='' size='540' side='right' caption='Caption for this structure' scene='78/781027/Panela/3'> | ||
===Fold=== | ===Fold=== | ||
<scene name='78/781027/Panela/3'>Panel A:</scene> The overall structure, shown as cartoon, has a fold common to other deubiquitinases (green) with a helix inserted between strand 1 and 2 (yellow). The protein belongs to the family of cysteine proteases, in which an active-site cysteine initiates hydrolysis by acting as a nucleophile. Just like serine proteases, cystein proteases have a catalytic triad (i.e. three highly conserved residues in the active site). The catalytic triad is shown in all-bonds representation. | <scene name='78/781027/Panela/3'>Panel A:</scene> The overall structure, shown as cartoon, has a fold common to other deubiquitinases (green) with a helix inserted between strand 1 and 2 (yellow). The protein belongs to the family of cysteine proteases, in which an active-site cysteine initiates hydrolysis by acting as a nucleophile. Just like serine proteases, cystein proteases have a catalytic triad (i.e. three highly conserved residues in the active site). The catalytic triad is shown in all-bonds representation. | ||
Revision as of 21:32, 30 April 2018
How this page was createdHow this page was created
The goal of this page is to make the figures found in the primary citation of the 5B5Q structure three-dimensional and interactive. The figures are closely modeled on Figure 2 panels A-E of the paper. Biochemistry students from Westfield State University have made drafts of the figures, and revised them after getting feedback from the researchers working on this protein. A special thank you goes to Ose Aimua, Nina Aldabayeva, Faiqa Ashraf, Kaleigh Florek, Ellie Hoeg, Aya Maytham, Christian Mikule, Brigid Murray, Kevin Pelletier, Brandon Reder, Erin Riley, Brian Schuler, and Jakob Wyman for the revisions on figures and links.
Chlamydia inhibits apoptosisChlamydia inhibits apoptosis
Chlamydia reproduces inside human cells. One defense of the human body against Chlamydia is to kill affected cells before Chlamydia reproduces. This is done through a process called apoptosis, programmed cell death. One player in apoptosis is the human protein Mcl-1. High Mcl-1 levels inhibit one of the signalling pathways that lead to apoptosis. Chlamydia inhibits Mcl-1 degradation so that Mcl-1 levels remain high.
Protein ubiquitination and degradationProtein ubiquitination and degradation
Human cells have a protein assembly called the proteasome, which specializes in degrading proteins. Ubiquitin is a small, highly soluble protein that is attached to other proteins as a signal. The proteasome only degrades proteins that are poly-ubiquitinated, i.e. are covalently linked to a linear chain of ubiquitins. The covalent link is between the amino group of a lysine side chain and the carboxylic acid of a glycine at the C-terminus of ubiquitin.
The deubiquitinase activity of Cdu1 stabilizes Mcl-1The deubiquitinase activity of Cdu1 stabilizes Mcl-1
The Chlamydia protein Cdu1 is a protease that catalyzes the hydrolysis of ubiquitin chains from Mcl-1. When polyubiquitinated, Mcl-1 is destined to be degraded by the proteasome, lowering the level of Mcl-1 and subsequently leading to apoptosis. The activity of Cdu1 counteracts this by removing the ubiquitin, thus leading to higher levels of Mcl-1 in the cell.
StructureStructure
Relevant LinksRelevant Links
5b5q : autogenerated Proteopedia page on coordinates
Ubiquitin Structure & Function : Proteopedia article on Ubiquitin Structure, function and conjugation
Ubiquitin chains : Proteopedia article on Ubiquitin Chains